Literature DB >> 2561401

Lymphopenia in primary degenerative dementia.

G D Tollefson1, M Godes, J B Warren, E Haus, M Luxenberg, M Garvey.   

Abstract

The central nervous and immune systems share a number of common properties, e.g. neurotransmitter receptors. In contrast to age matched healthy and/or hypertensive controls, the total lymphocyte count in 25 carefully diagnosed and staged patients with primary degenerative dementia were significantly reduced and also correlated with the severity of their dementia. Subjects' age, age of dementia onset, or duration of illness were unrelated. Total leukocyte counts were similar between groups. Nutritional status, ACTH, or plasma cortisol in dementia cohort were also not explanatory of their lymphopenia. These results are potentially significant in light of an immune hypothesis for primary degenerative dementia: Alzheimer's type and/or that population's high concomitant risk of infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2561401     DOI: 10.1016/0022-3956(89)90024-1

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  3 in total

Review 1.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

2.  The effect of citalopram on gene expression profile of Alzheimer lymphocytes.

Authors:  András Palotás; László G Puskás; Klára Kitajka; Miklós Palotás; József Molnár; Magdolna Pákáski; Zoltán Janka; Botond Penke; János Kálmán
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

3.  Association of peripheral immunity with cognition, neuroimaging, and Alzheimer's pathology.

Authors:  Jia-Hui Hou; Ya-Nan Ou; Wei Xu; Peng-Fei Zhang; Lan Tan; Jin-Tai Yu
Journal:  Alzheimers Res Ther       Date:  2022-02-09       Impact factor: 6.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.